Riding High On Investor Enthusiasm, BIO CEO 2014 Opens In New York
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi’s Chris Viehbacher says mutual respect, cultural understanding and close communication are keys to relationships with partners Alnylam and Regeneron; BIO survey confirms investor optimism for 2014; and RNAi panelists reflect on recent IPO glories.